Dunni Odumosu
Company: Bridge Bioscience Corp
Job title: Vice President of Global Regulatory Affairs
Seminars:
Strategizing for Regulatory Approval when Designing Clinical Trials for Neurological Gene Therapies 3:30 pm
Understanding how to set up your clinical trial design to please regulators Identifying novel biomarkers to CNS indications to utilize in clinical monitoring Accelerating clinical studies with endpoints to show disease modifying effects at a faster rateRead more
day: Conference Day Two
WORKSHOP F: Strategizing for Regulatory Approval when Designing Clinical Trials for Neurological Gene Therapies 1:00 pm - 4:00 pm
Many drug developers require clarity on acceptable clinical trial design and in utilizing optimal endpoints that will be accepted by the FDA. With so many gene therapies being placed on an accelerated timeline, it’s important to gain insights on strategies that will help you to gain successful regulatory approval. Join this workshop to learn: Understanding…Read more
day: CLINICAL TRACK PM